Literature DB >> 11757591

Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.

M E Rubio-Gozalbo1, D A van Waardenburg, P P Forget, L J Spaapen, A Verrips, P C Vroomen.   

Abstract

An 8 year-old boy with X-ALD under treatment with simvastatin developed a severe adverse reaction when the dose of his other medication, zuclopenthixol was increased. Both drugs were withdrawn after a diagnosis of neuroleptic malignant syndrome was made.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757591     DOI: 10.1023/a:1012480130445

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  3 in total

1.  Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy.

Authors:  A Verrips; M A Willemsen; E Rubio-Gozalbo; J De Jong; J A Smeitink
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

2.  Rhabdomyolysis and simvastatin.

Authors:  J P Deslypere; A Vermeulen
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

Review 3.  Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome.

Authors:  R J Gurrera
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.